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doi:10.1016/j.jtcvs.2004.04.023480 The Journal of Thoracic and CardioObjectives: Mediastinitis affects approximately 1% of children undergoing median
sternotomy. Conventional therapy involves debridement followed by open wound
care with delayed closure, days to weeks of closed suction or antimicrobial irriga-
tion, and vacuum-assisted closure or muscle flap closure. We hypothesized that
primary closure without prolonged suction or irrigation is an effective, less trau-
matic treatment for mediastinitis in children.
Methods: From January 1986 to July 2002, 6705 procedures involving median
sternotomy were performed at the C. S. Mott Children’s Hospital, resulting in 57
cases of mediastinitis (0.85%). Cases were divided into 2 groups, with 42 cases
treated with primary closure and 15 cases treated with delayed or muscle flap
closure. The 42 cases of primary closure comprised the primary study group of this
institutional review board-approved, retrospective analysis. Patient demographics,
surgical variables, mediastinitis-related parameters, and outcomes were evaluated.
Results: One patient had recurrent mediastinitis for an overall infection eradication
rate of 97% (40/41). Three patients (7%) required re-exploration for suspected
ongoing infection. Of these re-explorations, 1 patient had evidence of continued
mediastinitis. The remaining 2 patients with sepsis of unclear cause had no clinical
or culture evidence of recurrent infection. One of these patients ultimately died of
sepsis without active mediastinitis for a hospital survival of 97% (41/42). No
significant differences could be detected between the treatment successes and
failures in this small cohort of patients.
Conclusions: Simple primary closure is an effective means to treat selected cases of
postoperative mediastinitis in children. The results compare favorably with other
more lengthy or debilitating treatments.
Mediastinitis is a significant postoperative complication thataffects 0.1% to 5.0% of all pediatric patients undergoingmedian sternotomy.1-6 As in adults, treatment with debride-ment and primary closure in children has had reported failurerates of 50%.7 Current conventional therapy for mediastinitishas reduced mortality to 0% to 28%.8,9 The most popular
conventional techniques for the treatment of mediastinitis currently include debride-
ment followed by closure with either rectus abdominis or pectoralis major muscle
flaps and primary closure with days to weeks of closed suction drainage with or
without antimicrobial irrigation.10-12 These techniques, developed in adults, have
subsequently been applied to the pediatric population. However, concerns regarding
musculoskeletal growth, breast development, sternal instability, and other morbid-
ities associated with these complex and lengthy therapies have been raised.3-5,13
Since 1986, most cases of mediastinitis occurring at the C. S. Mott Children’s
Hospital of the University of Michigan Health System have been treated by
debridement with concomitant primary closure without muscle flaps, prolonged
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Dsuction, or irrigation. This policy is in sharp contrast with
the more common use of conventional therapies for medi-
astinitis in children. This report reviews our experience with




From January 1986 to July 2002, 6705 procedures involving a
median sternotomy were performed at our institution. All patients
who had mediastinitis in the postoperative period after median
sternotomy were identified. The data that were collected included
patient demographics, surgical parameters, and characteristics of
the infectious process. Demographic data included patient age,
weight, previous operations or episodes of mediastinitis, and both
cardiac and noncardiac diagnoses. Initial operative procedure, use
of prosthetic material, total cardiopulmonary bypass time, aortic
crossclamp time, incidence of delayed sternal closure, and, when
applicable, deep hypothermic circulatory arrest time were all re-
corded. Time from initial operation to the diagnosis of mediasti-
nitis, culture results, clinical severity of infection, recurrences,
morbidity, and mortality were evaluated.
Study Design
The current study is a single-center, retrospective review of the
medical records of children treated for postoperative mediastinitis.
Before the data were collected, appropriate institutional review
board approval was obtained. Patients with mediastinitis were
classified into 2 groups according to their method of treatment.
One group underwent debridement with concomitant primary clo-
sure without muscle flaps or prolonged suction/irrigation. The
second group underwent conventional therapy with debridement
and concomitant muscle flap closure or local wound care followed
by muscle flap closure, delayed primary closure, or healing by
secondary intention.
The study hypothesis was that primary closure is an effective
method for treating mediastinitis in children. The primary aim of
the study was to determine the success rate of primary closure. The
secondary aim was to compare the characteristics of the 2 groups
of patients undergoing either primary closure or conventional
therapy. It is important to distinguish between the outcomes of the
2 groups and the characteristics of the 2 groups in the secondary
aim. This is not a prospective study, and these are clearly 2
different populations of patients. The patients were treated over
many years, by several surgeons, with techniques that have
evolved over time. The patients were not selected for treatment in
a randomized fashion; rather they were selected according to
differences in the overall clinical condition and operative findings
determined by the individual surgeon. However, in an effort to
define these differences, the 2 groups were compared for variations
in patient demographics, surgical parameters, and infection char-
acteristics.
For the purposes of this study, mediastinitis was defined as
clinical and culture evidence of deep infection involving the peri-
cardial space after median sternotomy. A clinical grading scale
was used to classify severity of infection for use in later compar-
The Journal of Thoraciison between the groups undergoing primary closure and conven-
tional therapy. Mild mediastinitis was defined as fascial dehis-
cence, intact sternum, and free communication of purulent material
with the pericardial space at the sternal notch or xiphoid. Moderate
infection entailed sternal separation and purulence localized to the
anterior surface of the heart. Involvement of the entire pericardial
space with purulence was considered severe mediastinitis.
Surgical Technique
The decision to pursue primary closure or conventional therapy
was at the discretion of the operating surgeon. Our technique for
primary closure entailed initial debridement of all grossly infected
and devitalized soft tissue, cartilage, and bone. The sternum was
then closed with simple interrupted stainless steel wire over a
single chest tube. Running absorbable suture was used to close the
linea alba and soft tissue of the chest. The skin was closed with
interrupted nonabsorbable suture. The chest tube was managed as
a routine mediastinal drain. It was removed when postoperative
output had ceased, generally in 24 to 48 hours. All patients were
given a 6-week course of intravenous antibiotics. Conventional
therapies used at our institution included primary muscle flap
closure and open wound care followed by muscle flap closure,
delayed primary closure, or healing by secondary intention.
Statistical Analysis
The means for each group were compared using the Mann-Whit-
ney test and independent-samples t test. Normal Q-Q plots and
side-by-side box plots were used to examine normality and vari-
ance assumptions. Statistical significance was determined by com-
paring the generated t statistic and corresponding P value with an
alpha value of .5.
Results
A review of the 6705 procedures involving median sternot-
omy during the study period revealed 57 cases (0.85%) of
mediastinitis. Of the 57 cases, 42 (74%) were treated with
mediastinal debridement and concomitant primary closure.
Fifteen patients (26%) underwent treatment with conven-
tional therapies.
Patient Demographics
Comparison of the median age demonstrated no statistically
significant difference between the primary closure group
(6.7 months, range 6 days-75 months) and the conventional
therapy group (5.4 months, range 1 day-216 months) (Table
1). The median weight at operation was also similar be-
tween the primary closure group (6.3 kg, range 3-24.5 kg)
and the conventional therapy group (6.0 kg, range 4-70 kg).
Seventy-four percent (31/42) of patients in the primary
closure group had a cyanotic heart lesion, compared with
60% (9/15) in the conventional treatment group. Similar
results were also found for the percentages of single ven-
tricle lesions in the primary closure group (52%, 22/42) and
conventional therapy group (47%, 7/15).
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No statistically significant difference was found for mean
cardiopulmonary bypass time or aortic crossclamp time
between the primary closure group (93  34 minutes, 50 
18 minutes, respectively) and the conventional therapy
group (117  54 minutes, 39  12 minutes, respectively)
(Table 1). Prosthetic material, most commonly polytetra-
fluoroethylene patches or grafts and pulmonary homograft
patches or conduits, was used for repair in 60% (25/42) of
patients who underwent primary closure and 60% (9/15) of
patients who were treated with conventional therapy (Table
1). Sixty percent (25/42) of the patients who underwent
primary closure had undergone a previous sternotomy com-
pared with 52% (8/15) in the conventional therapy group. A
history of mediastinitis was found in 2 patients (5%) in the
primary closure group compared with none in the conven-
tional therapy group. However, the incidence of delayed
sternal closure at the initial operation was found to be higher
in the conventional therapy group (47%, 7/15) when com-
pared with the primary closure group (7%, 3/42, P .0018)
(Fig 1).
Mediastinitis-Related Variables
The median time from initial operation to the diagnosis of
Figure 1. Comparison of primary closure and conventional ther-
apy in patients: incidence of delayed sternal closure (P  .0018).
Figure 2. Comparison of primary closure and conventional ther-
apy in patients: incidence of Pseudomonas infection (P .05).mediastinitis was 13 days (range 6-32 days) for the primary
482 The Journal of Thoracic and Cardiovascular Surgery ● Septclosure group and 16 days (range 9-127 days) for the
conventional therapy group (Table 1). Staphylococcus spe-
cies were the most common causative agent in both groups.
It was isolated from 71% (29/41) of the primary closure
group and 55% (6/11) of the conventional closure group.
However, Pseudomonas was cultured in a significantly
higher proportion of the patients undergoing conventional
therapy compared with primary closure (45% vs 15%, re-
spectively, P  .05) (Fig 2). Comparison of the clinical
severity of mediastinitis revealed similar percentages of
mild, moderate, and severe infection in the 2 groups (Fig 3).
Results of Primary Closure for Mediastinitis
Hospital survival for the group of patients undergoing pri-
mary closure for mediastinitis was 97% (41/42). The hos-
pital death occurred from overwhelming sepsis in a patient
without evidence of active mediastinitis. There were no late
deaths related to sternal infection. Freedom from reinter-
vention for infectious complication was 93% (39/42). The 3
patients requiring reoperation had continuing sepsis and
required exploration for suspected ongoing mediastinitis. Of
these 3 patients, 2 had no clinical or culture evidence of
infection. One of these 2 patients was the single patient in
this group who later died of overwhelming sepsis. The 1
patient with continued mediastinal infection underwent suc-
cessful treatment with debridement and immediate muscle
flap closure. Therefore, the overall infection eradication rate
was 97% (41/42). The median length of stay was 12 days
(range 4-88 days).
Results of Conventional Therapy for Mediastinitis
The hospital survival for patients with mediastinitis treated
by conventional therapy was 27% (4/15). Three of the
patients died with active mediastinitis and ongoing open
wound care. These deaths were caused by systemic–pulmo-
nary artery shunt malfunction (1), aortic rupture (1), and
necrotizing enterocolitis (1). One patient died of fungal
Figure 3. Comparison of primary closure and conventional ther-
apy in patients: severity of mediastinitis. Mild infection (white);
moderate infection (diagonal lines); severe infection (black).sepsis 5 weeks after successful muscle flap closure, presum-
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Of the surviving patients, 1 patient (9%, 1/11) treated with
open wound care and delayed primary closure had recurrent
infection. The median length of stay for this group of
patients was 18 days (range 7-367 days).
Discussion
Mediastinitis remains a significant complication after me-
dian sternotomy in adults and children. The most common
conventional therapies currently used for children are mus-
cle flap closure, closed suction drainage with or without
antimicrobial irrigation, vacuum-assisted closure or local
wound care followed by muscle flaps, delayed primary
closure, or healing by secondary intention.1-6,13-15 All of
these strategies have been developed and proven in the adult
population, and subsequently applied to children. However,
all of these modalities have significant disadvantages in the
pediatric population. The use of rectus abdominis or pecto-
ralis major muscle flaps has the potential to cause muscu-
loskeletal growth abnormalities at either the donor or recip-
ient site. There is also the concern of future breast
development in girls associated with the use of pectoralis
major flaps.4,5,13 Closure with muscle flaps and healing by
secondary intention can lead to sternal instability with the
resultant physical deformity, lack of protection for the heart
and great vessels, and respiratory compromise. Other series,
including our experience, have reported patients with sig-
nificant sternal instability requiring reoperation for sternal
stabilization or contributing to ventilator dependence.5,13
Closed suction and antimicrobial irrigation have been re-
TABLE 1. Comparison of primary closure and conventiona
Variable Prima
Median age 6.7 mo (ran
Median weight 6.3 kg (ran
Cyanotic lesion 74% (31/42
Single ventricle lesion 52% (22/42
Prosthetic material 60% (25/42
Mean CPB time 93 min  3
Mean clamp time 50 min  1
Previous sternotomy 60% (25/42
Previous mediastinitis 5% (2/42)
Median time to diagnosis 13 d (range
CPB, Cardiopulmonary bypass.
TABLE 2. Comparison of the results of primary closure
contemporary studies using conventional therapy
Study Technique n
Current study Primary closure 42
Other studies3-5,14 Conventional therapy 36ported to cause significant metabolic derangement and even
The Journal of Thoracideath because of systemic absorption and toxicity of anti-
microbials in children.3 In addition, any prolonged wound
management strategy, particularly those requiring open
wound care, is physically and psychologically traumatic to
the pediatric patient.
Since 1986, it has been the policy at our institution to
treat the majority of cases of mediastinitis in children with
debridement and concomitant primary closure without pro-
longed suction or irrigation. Of the 57 cases of mediastinitis
identified over a 161⁄2-year period, 74% were treated with
primary closure. The technique of primary closure has re-
sulted in excellent rates of survival, freedom from reopera-
tion, and infection eradication. These results also compare
favorably with other reports in the literature of conventional
therapy for mediastinitis in children (Table 2). The median
length of stay of 12 days (range 4-88 days) also compares
well with other published results. Erez and colleagues5
reported a median length of stay of 34 days (range 23-150
days) for muscle flap closure. Although the total length of
stay was not addressed, Stiegel and associates3 published
their mean duration of intensive care unit stay for both flap
closure and local wound care with or without antimicrobial
irrigation as 6.2 days and 32.8 days, respectively.
In our experience, only 26% (15/57) of patients with
mediastinitis were treated with conventional therapy. Be-
cause these 2 treatment strategies were not randomly as-
signed, it is not particularly useful to compare outcomes.
However, determining how the 2 groups differed is of
interest. Although it is difficult to uncover all of the factors
that led to the decision to pursue conventional therapy rather
rapy groups: nonsignificant variables
sure Conventional therapy
d–75 mo) 5.4 mo (range 1 d–216 mo)




n 117 min  54 min
n 39 min  12 min
52% (8/15)
0%
d) 16 d (range 9-127 d)





97% (41/42) 7% (3/42) 3% (1/42)










6-32fromthan primary closure in this retrospective study, 2 of the
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with Pseudomonas and the need for delayed sternal closure
at the initial operation were both associated with the use of
conventional therapy. However, these factors should not be
misinterpreted as absolute or relative contraindications to
primary closure. Several patients who underwent successful
primary closure had either Pseudomonas infection or de-
layed sternal closure. It is possible that these variables are
surrogates for other parameters that are more difficult to
determine retrospectively, such as the extent of tissue de-
struction in the opinion of the operating surgeon or the
overall clinical condition of the patient. Because of the
limited numbers of patients, and the lack of randomization,
such conclusions and specific guidelines for the use of
primary closure or conventional therapy cannot be defined.
The fact that children and not adults tolerate primary
closure may be attributable to several factors. Many of the
risk factors associated with the development of mediastinitis
are found more commonly or even exclusively in adults.
Obesity, chronic obstructive pulmonary disease, and smok-
ing are widely recognized risk factors for the development
of mediastinitis.9,16,17 Advanced age alone is a risk factor
for mediastinitis, as well as for failure of successful treat-
ment.18 A more abundant vascular supply to the sternum in
children may also be a factor. The majority of adults un-
dergo a median sternotomy for coronary artery bypass graft-
ing. The same comorbidities associated with coronary artery
disease, such as hypertension and diabetes mellitus, are also
associated with vascular disease in general. In addition,
harvesting of the internal thoracic arteries for coronary
artery bypass grafting has been shown to result in ischemia
of the sternum.19 Children may also have a more developed
system of collateral circulation. The experience with coarc-
tation repair and extracorporeal membrane oxygenation has
shown that the subclavian artery and even the common
carotid artery may be ligated in children with relative im-
punity because of an abundance of collateral circulation.
Conversely, acute occlusion of the carotid artery or an
extremity artery in the adult often results in catastrophic
ischemia.
Primary closure is an effective treatment for mediastini-
tis in children. It is the treatment of choice at our institution
and is appropriate for the majority of cases. Selection of
primary closure or conventional therapy is based on the
clinical judgment of the surgeon regarding the overall con-
dition of the patient and the operative findings. The length
of time from initial operation to the diagnosis of mediasti-
nitis, presence of prosthetic material, and severity of medi-
astinitis based on a basic clinical grading scale are not
indicative of a need to select conventional therapy over
primary closure.
Specific recommendations based on these data are diffi-
cult because this is a nonrandomized observational study.
484 The Journal of Thoracic and Cardiovascular Surgery ● SeptIntuitively, those patients who are in poor clinical condition
may be better served with a conservative approach. This
inference is suggested by a higher incidence of Pseudomo-
nas infection and the need for delayed sternal closure at the
original operation in the conservative therapy group. Our
policy is to consider primary closure as the first option for
any patient with mediastinitis. Candidates for conventional
therapy include those with extensive tissue destruction in
whom sternal closure and soft tissue coverage of bone
would be problematic. In addition, patients with significant
hemodynamic compromise, who may not tolerate sternal
closure or even a minimal risk of ongoing mediastinitis,
should be considered for conventional therapy.
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Discussion
Dr Mohan Reddy (Stanford, Calif). I congratulate the authors
for their painstaking efforts to gather such a large amount of
retrospective data spanning over 15 years to shed light on a topic
that is often not considered mainstream.
Mediastinitis is a traumatic complication for the patient and
family and an annoying one for the surgeon. I agree with the
authors that aggressive debridement with primary closure is the
technique of choice in children, who often do not have any of the
risk factors that are often present in the adult population.
I have three questions for you, Dr Ohye. Did you identify any
risk factors predisposing to mediastinitis? I noticed in your article
that there is a preponderance of patients with cyanosis or single
ventricle lesions.
Second, has leaving the chest open in the operating room or
reopening in the intensive care unit been a risk factor for medias-
tinitis? In our experience, it has not been.
Finally, does prolonged antibody treatment in your group pre-
dispose to any superimposed fungal infections that had to be
treated?
Dr Ohye. Thank you, Dr Reddy, for your comments.
We did not analyze risk factors for mediastinitis. We only
looked at those patients who had mediastinitis. There was, as you
mentioned, a high incidence of patients with cyanotic lesions and
single ventricle lesions, which occurred in approximately 50% of
the patients. Whether either of these constitute a risk factor was not
determined, because we did not compare this cohort to the overall
group who did not have mediastinitis.
All of our patients, as you alluded to, underwent 6 weeks of
antibiotic therapy. We did have 1 patient who had a fungal super-
infection during that period of treatment. Otherwise, we did not
have any other significant complications, other than 1 patient who
lost the peripherally inserted central catheter line and completed
the final 2 weeks of antibiotics orally.
Dr Carl Backer (Chicago, Ill). I congratulate you on your low
incidence of mediastinitis, and I also believe that you are on the
right track with the early primary closure.
We have reported our results with mediastinitis at Children’s
Hospital, and we would tend to agree with you, with the exception
that we were using vascularized muscle flaps for almost all of the
patients.
Depending on the severity of the mediastinitis (and I think there
is a little selection bias in your review), I think the introduction of
a muscle flap for the patients with a true mediastinitis can be of
significant help for the patient, particularly if there is an esopha-
geal injury or a tracheal injury that caused the initial mediastinitis.
I believe that there is going to be another arm to the algorithm
that you showed, and our plastic surgeons have been using the
vacuum-assisted system in the last year.
We had a dramatic case of a patient with failed Fontan con-
version and protein-losing enteropathy who underwent a heart
transplant and reoperation for bleeding, and who had an open chest
for 6 days. We irrigated the patient’s chest, closed the sternum
with wire, and then put this vacuum sponge with the vacuum
system on. With all those risk factors (immunosuppression, pro-
The Journal of Thoracitein-losing enteropathy, and failed Fontan), this child survived and
his sternum healed very nicely. We have since used it in 2 other
patients with some success.
What do you think about the vacuum system? Have you used it
at all, and do you think that will be another part of our armamen-
tarium in the future?
Dr Ohye. Thank you, Dr Backer.
I am aware of that therapy; it was used in a published study on
adults. Do you use an antibiotic-impregnated sponge, as has been
previously described?
Dr Backer. No.
Dr Ohye. For those not familiar with this therapy, a sponge is
placed in the wound to which high vacuum is applied. The sponge
basically distributes the vacuum throughout the wound and pulls
the wound closed more quickly.
We have not used this technique. I think it would be an
excellent technique; however, obviously there are still advantages
to primary closure in that the wound is closed simply and imme-
diately.
I do not believe that there is a huge amount of selection bias.
When we compared the severities between the 2 groups (conven-
tional therapy vs primary closure), there was no difference in
severity, at least when using our clinical index of severity.
Dr Constantine Mavroudis (Chicago, Ill). Did you use bone
wax?
Dr Ohye. We generally do not and essentially never in younger
children. I do not find it necessary. I will rarely use it in adults and
adolescents, only if there is significant, difficult to control sternal-
edge bleeding.
Dr Marshall L. Jacobs (Philadelphia, Pa). My compliments
on a clear presentation. On the basis of a smaller experience, we
certainly concur with your preference for primary closure.
My question pertains to the subset of patients with single
ventricle anomalies in particular. In some centers, there seems to
be a pattern of behavior on the part of the cardiologists that
involves catheter techniques to coil embolize “collateral vessels”
that often includes the internal thoracic arteries.
Although there are conflicting data as to the efficacy of that
from the standpoint of a hemodynamic benefit, it certainly affects
the local blood supply to the chest wall.
Was that phenomenon of coil occlusion of internal thoracic
arteries apparent at all in your single ventricle population? If that
phenomenon were present, would it affect your decision to per-
form primary closure without bringing omentum or muscle or
something else to increase the local blood supply?
Dr Ohye. We did not specifically look to see whether any of
the patients had undergone coiling of their internal thoracic arter-
ies. But to answer your question, no, it really would not change my
management. The default position would still be to perform a
primary closure on those patients.
Dr Christian Brizard (Melbourne, Australia). Congratulations
on your article. I just would like to remind the audience that this
technique of primary closure with a high vacuum level of drainage
was presented and published by Ebluquant in 1988, with at that
time about 6 years of experience.
Dr Mavroudis. Can you tell us about the findings?
Dr Brizard. It is derived from what the orthopedic surgeonsused for the infection of joints. It usually concludes with a short
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complication.
Dr Mavroudis. Thank you for reminding us of that important
article.
Dr Richard A. Jonas (Boston, Mass). I thank Dr Ohye and the
group in Michigan for putting this together. It takes courage to
publish the world’s largest series of mediastinitis.
The problem that we often face is that we frequently have
infectious disease consultants who read the adult literature and
rotating residents from adult services who are familiar with the
way that adults are handled, and there can be a lot of resistance to
a conservative approach, which certainly has been our approach,
so we absolutely concur with your conclusions.
I have a question on a related topic. You might not have any
data, but we face the same issue with patients who have positive
blood cultures who have had patches or valves or other prosthetic
material implanted. It has been my sense that we can safely use
short periods of intravenous antibiotics in this situation. However,
once again, one faces resistance and skepticism from infectious
disease consultants and residents.
Can you tell us your policy in Michigan regarding positive
blood cultures when one has bioprosthetic implants?
Dr Ohye. I have exactly the same experience in that there is an
automatic urge to give patients 6 weeks of antibiotics for any
infection. Even if patients have a superficial wound infection with
or without positive blood cultures, they can be sent home with 6
weeks of antibiotics if you do not intervene. For superficial wound
infections without positive blood cultures, I do not think it is486 The Journal of Thoracic and Cardiovascular Surgery ● SeptTo specifically answer your question about blood cultures, my
personal preference for patients who are clinically doing well with
a single positive culture and an autologous or polytetrafluoroeth-
ylene patch, in the absence of echocardiogram findings of any
suspicious clot or vegetation, is to give them intravenous antibi-
otics for 2 weeks. I am more conservative with patients who appear
toxic or who have multiple positive cultures, vegetations or clots,
or prosthetic valves; I would lean toward a 6-week course. These
are my opinions, based on clinical experience and not randomized
data.
Dr Peter B. Manning (Cincinnati, Ohio). I am sure a compo-
nent of your success that you did not really detail is attention to
nutrition in these children.
Although hyperal has been around for 20 years, I think in the
last 10 years we have done a better job of maintaining good
nutrition in this complex group of kids. I would be curious if you
would comment on what your strategy is nutritionally (intravenous
vs enteral) and how closely you followed that in this group of kids.
Dr Ohye. Yes, I think that nutrition is important. We did not
look at that as a variable for defining which patients had primary
closure or conventional therapy or which patients had mediastinitis
in the first place. I do echo your feelings about the importance of
nutrition.
Our overall policy is that we generally give patients intrave-
nous nutrition soon after their operations, especially those who are
unlikely to be enterally fed soon, and then transition as quickly as
we can to enteral feeding. Even if it is just trophic feeding, Inecessary to give patients 6 weeks of antibiotics. believe that enteral nutrition is important.ember 2004
